Head-to-Head Comparison Of Oral Hepatitis C Drugs Funded By PCORI
This article was originally published in The Pink Sheet Daily
Executive Summary
Study will use patient registry to compare Harvoni, Viekira Pak and Merck’s upcoming grazoprevir/elbasvir fixed-dose combination pill in patient groups that have been under-represented in clinical trials.